The Case of Baxter’s Moldy HEPA Filters
Executive Summary
It looked like mold was growing on the filters supplying air to the cleanroom where workers filled IV bags. Why didn’t anyone deal with it? Case study shows what can happen when whistleblower concerns are not investigated and taken seriously.
You may also be interested in...
Code Cart Crisis: Anatomy Of An Emergency Drug Shortage
How FDA, health care providers, and Pfizer and other drug makers are responding to a shortage of emergency medicines from the fragile, overstressed US sterile injectables sector.
Unusual False-Claims Settlement Cites GMP Issues
A recent Baxter settlement over moldy air filters shows a move for DOJ to enforce manufacturing quality violations as part of its False Claims Act activities.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.